Mumbai receives import bids for Sputnik, preps for 60-day vaccination drive

Mumbai estimates to spend 7 billion rupees to buy shots informed municipal commissioner Iqbal Singh Chahal.

Sputnik
Sputnik V. Photo: Bloomberg
Dhwani Pandya | Bloomberg
2 min read Last Updated : May 19 2021 | 12:53 PM IST
Mumbai’s municipality has received bids to import 10 million Sputnik vaccines and expects more proposals as authorities attempt an ambitious plan to vaccinate every resident of the world’s second-most densely packed city within two months.

India’s financial capital estimates to spend about 7 billion rupees ($96 million) to buy the shots, Municipal Commissioner Iqbal Singh Chahal told Bloomberg TV in an interview on Wednesday. Faster vaccinations could help avert a third wave of the coronavirus, which could cost the city above 8 billion rupees just to run its temporary hospitals created to tackle a surge in patients.

Mumbai has been the epicenter of India’s virus outbreak in both previous waves, though it has received praise for flattening the curve relatively quickly. Last week it became the first city in the country to independently seek to import vaccines as local manufacturers struggle to keep up with demand.

“Once we get 15 million vaccine shots, I plan to vaccinate the entire city in next 60 days and by doing so I am very sure we will be able to stop the third wave from coming,” Chahal said.

The three bids received include a proposal from London-based Taliesin International Ltd. and two other companies from Hyderabad, India, which claim authorized distributorship from Sputnik marketer The Russian Direct Investment Fund, Chahal said by phone.


The city needs 10 million shots for vaccinating people aged 18-45 years and another 5 million for older residents.

The import tender, which was due to close May 18, will be extended until May 25 when a final decision will be taken, Chahal said. All large global manufacturers are invited including Pfizer Inc., Moderna Inc., Johnson & Johnson, Serum Institute of India Ltd. and Bharat Biotech Ltd.

About 5% of tests conducted in Mumbai are currently throwing up positive results, down from 31% a month ago. The so-called positivity rate will drop to 2% by the end of May, Chahal said.


India is still reporting an overall positivity rate of about 20%, far higher than the less-than-5% the World Health Organization considers as an indicator that the spread is under control.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusMumbaiCoronavirus VaccineSerum Institute of India

Next Story